Oracle

Loreli Cadapan Joins Liquibase as Vice President of Product

Retrieved on: 
Tuesday, March 19, 2024
Database, Computer science, Massachusetts Institute of Technology, Partnership, MIT, DevOps, Artificial intelligence, Software, Bachelor, Woman, STEM, Oracle, Stanford University, ActiveState, Management

AUSTIN, Texas, March 19, 2024 /PRNewswire/ -- Leading database change management solution Liquibase announces the appointment of Loreli Cadapan as Vice President of Product. The MIT alum and ex-Oracle Director of DevOps unites her expertise in leading and building DevOps teams and products as she charts a user-centric roadmap expanding the uses, capabilities, and values of database CI/CD. Building on Liquibase's open-source foundation and core automation, governance, and observability features, Cadapan strives to bring DevOps integration to all of the world's data stores.

Key Points: 
  • AUSTIN, Texas, March 19, 2024 /PRNewswire/ -- Leading database change management solution Liquibase announces the appointment of Loreli Cadapan as Vice President of Product .
  • "As a DevOps devotee and longtime Liquibase user, I know how game-changing it is to extend DevOps to the database," says Cadapan.
  • In 2017, Cadapan kicked off a five-year stint at DevOps/DevSecOps platform JFrog as Sr. Director of Product, building the U.S. product team from the ground up.
  • Prior to joining Liquibase in December 2023, she spent two years as Chief Product Officer at ActiveState with its enterprise DevSecOps platform for software supply chain security.

AI Innovators Flock to Oracle to Address Some of the World's Most Pressing Challenges

Retrieved on: 
Monday, March 18, 2024
Cloud, Natural language processing, GPU, Growth, Oracle Cloud, HPC, OCI, AI, Graphics processing unit, Data management, Oracle, Music, Machine learning, Trailblazer, Modal, Engineering, Video game

AUSTIN, Texas, March 18, 2024 /PRNewswire/ -- AI trailblazers are using Oracle Cloud Infrastructure (OCI) AI Infrastructure and OCI Supercluster to support the development and deployment of production-ready AI, including large language model training for generative AI applications. An influx of AI companies including Modal, Suno, Together AI, and Twelve Labs are deploying OCI AI Infrastructure to accelerate AI training and inferencing at scale.

Key Points: 
  • An influx of AI companies including Modal, Suno, Together AI, and Twelve Labs are deploying OCI AI Infrastructure to accelerate AI training and inferencing at scale.
  • With OCI AI Infrastructure, AI companies have access to high-performance GPU clusters for machine learning, image processing, model training, inference computation, physics-based modeling and simulation, and massively parallel HPC applications.
  • "AI innovators have a small margin of error when it comes to deploying AI infrastructure," said Greg Pavlik, senior vice president, AI and Data Management Services, Oracle Cloud Infrastructure.
  • Together AI is a research-driven AI company providing the fastest cloud platform for inference and training of generative AI models.

Arkansas Heart Hospital Extends Oracle Health EHR and Patient Accounting Across Its Network

Retrieved on: 
Wednesday, March 13, 2024
Cloud, Diagnosis, Health, Oracle Fusion Applications, SCM, Cardiovascular disease, Documentation, Patient, Public, ERP, Hospital, Artificial intelligence, Doctor of Philosophy, MD, HIMSS, Oracle, EHR, Nursing

AUSTIN, Texas, March 13, 2024 /PRNewswire/ -- Arkansas Heart Hospital , a leader in prevention, diagnosis, and treatment of cardiovascular disease, is extending its use of Oracle Health electronic health records (EHR) and RevElate Patient Accounting solutions across its network of ambulatory clinics and two hospitals.

Key Points: 
  • AUSTIN, Texas, March 13, 2024 /PRNewswire/ -- Arkansas Heart Hospital , a leader in prevention, diagnosis, and treatment of cardiovascular disease, is extending its use of Oracle Health electronic health records (EHR) and RevElate Patient Accounting solutions across its network of ambulatory clinics and two hospitals.
  • This will help the network more easily share important data, improve staff and patient experiences, and better align resources with patient needs.
  • "Since we opened nearly 27 years ago, innovation has been a driving force that separates Arkansas Heart from the competition," said Bruce Murphy, MD, PhD, CEO and founder, Arkansas Heart Hospital.
  • By extending its 10-year relationship with Oracle Health, Arkansas Heart can improve how its staff works and delivers care by having a single, longitudinal health record for each patient, no matter which Arkansas Heart facility they visit.

8VC Names Karen White as Executive Partner

Retrieved on: 
Wednesday, March 13, 2024
Microsoft, Moody's Investors Service, Software as a service, Apple, Learning, OpenGov, SolarWinds, Internet, RMS, Acquisition, IPO, Addepar, Syncplicity, Oracle, EMC, Marketing, Cryptocurrency

AUSTIN, Texas, March 13, 2024 /PRNewswire/ -- 8VC, a leading venture capital firm managing over $6 billion in committed capital, announced the addition of Karen White as Executive Partner.

Key Points: 
  • AUSTIN, Texas, March 13, 2024 /PRNewswire/ -- 8VC, a leading venture capital firm managing over $6 billion in committed capital, announced the addition of Karen White as Executive Partner.
  • Karen has been a driving force behind several multi-billion-dollar companies, and brings her extraordinary history of innovation, transformation, and hypergrowth to 8VC.
  • From the 8VC platform, Karen will also co-found and lead a new technology company, to be announced at a later date.
  • According to 8VC General Partner Joe Lonsdale, "I've had the privilege of learning from and working closely with Karen for over a decade.

Oracle Delivers Foundation for More Intelligent Healthcare

Retrieved on: 
Tuesday, March 12, 2024
Cloud, RN, Health, ROI, Government, Risk management, Intelligence, Diabetes, Patient, Oracle Cloud, Public, DNP, Health information management, OCI, AI, IDC, Overalls, HIMSS, Address, Immunization, Oracle, Breast cancer, CCM, EHR, Medicare, Update, Medical device

AUSTIN, Texas, March 12, 2024 /PRNewswire/ -- Oracle today announced significant enhancements to Oracle Health Data Intelligence, including a new generative AI service to help increase care management efficiency. Oracle Health Data Intelligence, formerly HealtheIntent, is a modular suite of cloud applications, services, and analytics. The suite enables a broad range of healthcare and government stakeholders to use data from across the healthcare ecosystem to help advance patient health, improve care delivery, and drive operational efficiency. Additional new capabilities include system performance improvements, pre-built clinical quality analytics, and automated alerts that can help increase reimbursements and enhance care.

Key Points: 
  • Oracle Health Data Intelligence, formerly HealtheIntent, is a modular suite of cloud applications, services, and analytics.
  • Powered by Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence gives customers access to the same mission-critical security, performance, reliability, and other cloud capabilities that Fortune 100 customers in highly regulated industries rely on today.
  • To see Oracle Health in action, please visit us at HIMSS in Orlando March 11 - 15 at booth #2761.
  • Learn how Oracle Health is building an open healthcare platform with intelligent tools for data-driven, human-centric health experiences to connect consumers, providers, payers, public health, and life sciences.

Oracle Announces Fiscal 2024 Third Quarter Financial Results

Retrieved on: 
Monday, March 11, 2024
Cloud, Oracle Corporation, Software as a service, Cerner, Cloud computing, Infrastructure as a service, Oracle, GAAP, Software

"In Q3, Oracle finished moving the majority of Cerner customers to Oracle's Gen2 Cloud Infrastructure," said Oracle Chairman and CTO, Larry Ellison.

Key Points: 
  • "In Q3, Oracle finished moving the majority of Cerner customers to Oracle's Gen2 Cloud Infrastructure," said Oracle Chairman and CTO, Larry Ellison.
  • This dividend will be paid to stockholders of record as of the close of business on April 10, 2024, with a payment date of April 24, 2024.
  • Oracle will hold a conference call and webcast today to discuss these results at 4:00 p.m. Central.
  • A live and replay webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor/ .

Code and Theory, a Stagwell (STGW) Network Company, Named Ad Age Business Transformation Agency of the Year

Retrieved on: 
Monday, March 11, 2024
ROI, Growth, Amazon, Partnership, SXSW, Perception, Web Summit, Acquisition, AI, Figma, Consolidated Edison, Creativity, Oracle, Beyond Words

NEW YORK, March 11, 2024 /PRNewswire/ -- Code and Theory, part of Stagwell (NASDAQ: STGW), has been named the Ad Age Business Transformation Agency of the Year. The technology-first creative agency was recognized for its ability to drive significant results for its clients. 

Key Points: 
  • NEW YORK, March 11, 2024 /PRNewswire/ -- Code and Theory , part of Stagwell (NASDAQ: STGW), has been named the Ad Age Business Transformation Agency of the Year .
  • Code and Theory is the only agency with 50% engineers and 50% creatives at scale.
  • To better serve its roster of blue-chip clients, Code and Theory doubled down on technology, struck expansive new partnerships and added key executives.
  • Code and Theory CEO Michael Treff says, "We are at an inflection point for clients looking to undergo true business transformation.

Vittoria Therapeutics Announces Appointment of Life Sciences Veteran Rosemary Mazanet, M.D., Ph.D. as Chief Medical Officer

Retrieved on: 
Tuesday, February 27, 2024
Therapy, Oracle, Research, Amgen, Drug development, T-cell lymphoma, University, CD5, Patient, Internal medicine, Drug, Disease, Biology, Infection, Nursing

PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, a clinical-stage cell therapy company, has announced today that accomplished life sciences leader, Rosemary Mazanet, M.D., Ph.D., has joined the Company as Chief Medical Officer.

Key Points: 
  • PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, a clinical-stage cell therapy company, has announced today that accomplished life sciences leader, Rosemary Mazanet, M.D., Ph.D., has joined the Company as Chief Medical Officer.
  • “Drawing on her extensive expertise in the oncology and hematology drug development ecosystem, Dr. Mazanet will be an invaluable asset to Vittoria’s executive team as we enter first-in-human studies for our lead program,” said Nicholas Siciliano, Ph.D., Vittoria’s Chief Executive Officer.
  • Vittoria’s innovative approach to CAR-T development could change the treatment paradigm for T-cell lymphoma patients struggling with this debilitating disease.
  • Dr. Mazanet received her clinical training in internal medicine and oncology at Harvard Hospitals.

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Retrieved on: 
Monday, February 26, 2024
Oracle, Mothercare, Photoprotection, Excipient, US FDA, Skin, Pregnancy, Safety, Foul, NetSuite, Food and Drug Administration, Protein, Quality management system, CGMP, Good manufacturing practice, Cosmetics

PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced that they have completed product development of their Gold Limited Edition Exclusive (G.L.E.E.)

Key Points: 
  • PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced that they have completed product development of their Gold Limited Edition Exclusive (G.L.E.E.)
  • product for commercial launch in March 2024.
  • Additionally, the Company is in advanced stages of development and testing of 9 other skincare products anticipated to launch over Spring and Summer 2024.
  • The Carmell skincare product portfolio:
    Carmell G.L.E.E.

Fansee Embarks on a Revolutionary Path under the Leadership of Visionary CEO Jason Hung

Retrieved on: 
Thursday, February 22, 2024
Social media, Oracle, Fortune 500, Networking hardware, Hung, AI, Investment, Growth, Health care, Ernst & Young, Privacy, Motion, Cryptocurrency

With over 25 years of experience in the tech and startup sectors, Hung's visionary leadership is set to elevate FanSee to unprecedented heights, merging innovation with user-centric solutions.

Key Points: 
  • With over 25 years of experience in the tech and startup sectors, Hung's visionary leadership is set to elevate FanSee to unprecedented heights, merging innovation with user-centric solutions.
  • This wave of enthusiasm has propelled FanSee into a critical financing phase, with several collaborations already in motion.
  • As FanSee forges ahead with its strategic initiatives, the company, under Jason Hung's visionary leadership, invites investors and partners to join in reshaping the social media landscape.
  • With a focus on innovation, security, and user empowerment, FanSee is poised to become a frontrunner in the next generation of social networking.